Home
October 2008 November 2008 December 2008
Su Mo Tu We Th Fr Sa
Week 44 1
Week 45 2 3 4 5 6 7 8
Week 46 9 10 11 12 13 14 15
Week 47 16 17 18 19 20 21 22
Week 48 23 24 25 26 27 28 29
Week 49 30

Male Infertility & Reproduction
UroToday's Male Infertility section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of male infertility. Also available are conference coverage for all timely male infertility science, audio podcasts and downloadable slides from UroToday's slide library.
Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display results per page
Results 241 - 255 of 264
<< Start < Prev 11 12 13 14 15 16 17 18 Next > End >>
Human Enzyme Produced by Pseudomonas Aeruginosa
Tuesday, 03 February 2004
NEW YORK (Reuters Health) - Pseudomonas aeruginosa appears to produce lipoxygenase, an enzyme that until now has only been identified in cells from other eukaryotes and humans, according to a new report.
read more

Selective Cytology Usage Aids in Hematuria Evaluations
Thursday, 22 January 2004
BERKELEY, CA (UroToday Inc.) - The American Urological Association established its Best Practice Policy on Asymptomatic Microscopic Hematuria in 2001. These guidelines recommend cytology only in patients with risk factors for transitional cell carcinoma. Drs. Chris Hofland and Albert Mariani report their findings regarding the usefulness of cytology in hematuria workups in the January 2004 issue of the Journal of Urology.
read more

Britain to Lift Anonymity From Sperm, Egg and Embryo Donors
Wednesday, 21 January 2004
LONDON (Reuters Health) - Public Health Minister Melanie Johnson said on Wednesday new rules would be introduced to allow children conceived as a result of sperm, egg and embryo donations to find out the identity of their donor.
read more

Growth Factors May Improve Results of Assisted Reproduction
Friday, 16 January 2004
NEW YORK (Reuters Health) - Epidermal growth factors (EGFs) induced by the midcycle surge of luteinizing hormone (LH) appear to act as paracrine mediators of follicle maturation and ovulation, investigators in California report. Elucidation of these mechanisms may lead to improvements in fertility treatments or in vitro fertilization.
read more

Sperm Counts Have Fallen by a Third in Scotland
Monday, 05 January 2004
LONDON (Reuters Health) - Sperm counts among men seeking infertility treatment dropped by almost a third over the past 14 years, according to a Scottish study that rekindles fears about declining male fertility.
read more

Screening for Proteinuria Not Cost Effective for Normotensive Middle-Aged Adults
Tuesday, 16 December 2003
NEW YORK (Reuters Health) - Routine screening for urine protein is cost-effective only when limited to high-risk groups, such as those aged 60 and above or those with hypertension or diabetes, physicians at Johns Hopkins Medical Institutions report.
read more

Patients with Prostatitis NIH IIIB (Prostatodynia) Show Significant Abnormalities of Ejaculate
Wednesday, 10 December 2003
In their introduction to this article, Drs. Engeler, Hauri and John of St. Gallen, Switzerland point out that prostatitis and male infertility each account for about 8% of all urologic office visits. However, the relationships between the two ?remain obscure?.
read more

Germ Stem Cell-derived Sperm Cells Capable of Fertilizing Oocytes
Wednesday, 10 December 2003
NEW YORK (Reuters Health) - Fertile, male haploid germ cells now join the ranks of cell types that can be generated from embryonic stem cells, scientists in Massachusetts report in the early edition of Nature, available online December 10.
read more

Patients with Prostatitis NIH IIIB (Prostatodynia) Show Significant Abnormalities of Ejaculate
Wednesday, 10 December 2003
In their introduction to this article, Drs. Engeler, Hauri and John of St. Gallen, Switzerland point out that prostatitis and male infertility each account for about 8% of all urologic office visits. However, the relationships between the two ?remain obscure?.
read more

Receptor Gene Plays Key Role in Regulating Puberty
Thursday, 23 October 2003
NEW YORK (Reuters Health) - An intact G protein-coupled receptor gene (GPR54) seems to be necessary for normal puberty to occur in both humans and mice, according to a report published in the October 23rd issue of The New England Journal of Medicine.
read more

High Dairy Product Intake Associated with an Increased Testicular Cancer Risk
Monday, 13 October 2003
NEW YORK (Reuters Health) - Canadian men who have high levels of dairy product consumption have an increased risk of testicular cancer, according to the results of a study published in the October 10th issue of the International Journal of Cancer.
read more

Marijuana Smoking Affects Seminal Fluid, Sperm
Monday, 13 October 2003
SAN ANTONIO (Reuters Health) - A new study shows that men who smoke marijuana frequently have significantly less seminal fluid, a lower total sperm count and abnormally behaving sperm.
read more

Dramatic Increase Seen in Antibiotic-resistant Gut Bacteria
Wednesday, 17 September 2003
CHICAGO (Reuters Health) - The prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in the feces of both the hospitalized and general populations has increased significantly over the last decade, a Spanish team of investigators report.
read more

Savient Pharmaceuticals, Inc. Announces FDA Approval of New Manufacturing Site for Delatestryl, Savient's Injectable Testosterone Product
Monday, 08 September 2003
EAST BRUNSWICK, N.J., Sept. 8, 2003--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the U.S. Food and Drug Administration has approved a new manufacturing site for the manufacture of Delatestryl(R) (testosterone enanthate injection), Savient's injectable testosterone product for the treatment of hypogonadism. Savient has entered into a supply agreement with the new manufacturer, Sabex, a Canadian manufacturer and marketer of pharmaceutical products, to manufacture Delatestryl for Savient for the U.S. market.
read more

Quinolone-related Achilles Tendon Rupture Risk High in Elderly on Corticosteroids
Monday, 11 August 2003
NEW YORK (Reuters Health) - Current or past treatment with quinolones is tied to an increased risk of Achilles tendon rupture, especially in elderly patients who are also taking oral corticosteroids, new research suggests.
read more

 
<< Start < Prev 11 12 13 14 15 16 17 18 Next > End >>
Results 241 - 255 of 264